Blockade of collagen-induced arthritis post-onset by antibody to granulocyte-macrophage colony-stimulating factor (GM-CSF): requirement for GM-CSF in the effector phase of disease.
Blockade of collagen-induced arthritis post-onset by antibody to granulocyte-macrophage colony-stimulating factor (GM-CSF): requirement for GM-CSF in the effector phase of disease.
复制标题
DOI:
10.1186/ar318
复制
发表时间:
2001
期刊:
影响因子:
--
通讯作者:
Hamilton JA
中科院分区:
文献类型:
--
作者:
Cook AD;Braine EL;Campbell IK;Rich MJ;Hamilton JA
There is mounting evidence for a role of the growth factor granulocyte-macrophage colony-stimulating factor (GM-CSF) in inflammatory disease, including arthritis. In the present study, we examined the effectiveness of treatment of collagen-induced arthritis (CIA) with a neutralizing mAb to GM-CSF. DBA/1 mice were immunized for the development of CIA and treated at different times, and with different doses, with neutralizing mAb to GM-CSF or isotype control mAb. Anti-GM-CSF mAb treatment prior to the onset of arthritis, at the time of antigen challenge, was effective at ameliorating the ensuing disease. Modulation of arthritis was seen predominantly as a reduction in overall disease severity, both in terms of the number of limbs affected per mouse and the clinical score of affected limbs. Importantly, anti-GM-CSF mAb treatment ameliorated existing disease, seen both as a reduction in the number of initially affected limbs progressing and lower numbers of additional limbs becoming affected. By histology, both inflammation and cartilage destruction were reduced in anti-GM-CSF-treated mice, and the levels of tumor necrosis factor-a and IL-1? were also reduced in joint tissue washouts of these mice. Neither humoral nor cellular immunity to type II collagen, however, was affected by anti-GM-CSF mAb treatment. These results suggest that the major effect of GM-CSF in CIA is on mediating the effector phase of the inflammatory reaction to type II collagen. The results also highlight the essential role of GM-CSF in the ongoing development of inflammation and arthritis in CIA, with possible therapeutic implications for rheumatoid arthritis.
登录
查看更多内容
影响因子:
3.8
作者:
BRISSETTE, WH;BAKER, DA;GRIFFITHS, RJ
通讯作者:
GRIFFITHS, RJ
影响因子:
20.3
作者:
Metcalf, D;Robb, L;DiRago, L
通讯作者:
DiRago, L
影响因子:
5.6
作者:
HAMILTON, JA;STANLEY, ER;SHADDUCK, RK
通讯作者:
SHADDUCK, RK
影响因子:
15.3
作者:
Alvaro-Gracia, J M;Zvaifler, N J;Firestein, G S
通讯作者:
Firestein, G S
DOI:
10.1073/pnas.89.20.9784
发表时间:
1992-10-15
影响因子:
11.1
作者:
WILLIAMS, RO;FELDMANN, M;MAINI, RN
通讯作者:
MAINI, RN